{"protocolSection":{"identificationModule":{"nctId":"NCT01610414","orgStudyIdInfo":{"id":"115523"},"secondaryIdInfos":[{"id":"2012-000138-20","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A","officialTitle":"Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A"},"statusModule":{"statusVerifiedDate":"2017-12","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2012-07-13","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2016-11-04","type":"ACTUAL"},"completionDateStruct":{"date":"2017-02-01","type":"ACTUAL"},"studyFirstSubmitDate":"2012-05-31","studyFirstSubmitQcDate":"2012-05-31","studyFirstPostDateStruct":{"date":"2012-06-04","type":"ESTIMATED"},"resultsFirstSubmitDate":"2017-11-03","resultsFirstSubmitQcDate":"2017-12-20","resultsFirstPostDateStruct":{"date":"2018-01-23","type":"ACTUAL"},"lastUpdateSubmitDate":"2017-12-20","lastUpdatePostDateStruct":{"date":"2018-01-23","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The purpose of this study is to evaluate the efficacy of GSK Biologicals' vaccine GSK1437173A in the prevention of Herpes zoster (HZ) in autologous haematopoietic cell transplant recipients 18 years of age and older. To this end, the study will evaluate vaccine efficacy (VE) of the GSK1437173A vaccine, administered on a 2-dose schedule, compared to placebo in reducing the risk of developing HZ in this population."},"conditionsModule":{"conditions":["Herpes Zoster"],"keywords":["Observer-blind","Efficacy","Immunogenicity","Vaccination","Safety","Adult autologous haematopoietic cell transplant recipients","Herpes Zoster"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":1877,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"GSK1437173A Group","type":"EXPERIMENTAL","description":"Subjects received 2 doses of the candidate HZ vaccine GSK 1437173A, administered intramuscularly (IM) in deltoid region of non-dominant arm, according to a 0, 1 Month schedule.","interventionNames":["Biological: Herpes Zoster vaccine GSK1437173A"]},{"label":"Placebo Group","type":"PLACEBO_COMPARATOR","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of non-dominant arm, according to a 0, 1 Month schedule.","interventionNames":["Biological: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Herpes Zoster vaccine GSK1437173A","description":"2 doses administered intramuscularly (IM) in deltoid region of non-dominant arm","armGroupLabels":["GSK1437173A Group"]},{"type":"BIOLOGICAL","name":"Placebo","description":"2 doses administered IM in deltoid region of non-dominant arm","armGroupLabels":["Placebo Group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Subjects With Confirmed Herpes Zoster (HZ) Episode","description":"A suspected case of HZ was defined as (1) a new rash characteristic of HZ (e.g., unilateral, dermatomal and accompanied by pain broadly defined to include allodynia, pruritus or other sensations), or a vesicular rash suggestive of VZV infection regardless of the distribution, and no alternative diagnosis; or (2) a clinical presentation (symptoms and/or signs) and specific laboratory findings\\* suggestive of VZV infection in the absence of characteristic HZ or VZV rash.\n\nA suspected case of HZ was confirmed either: by Polymerase Chain Reaction (PCR) or by the HZ Ascertainment Committee (HZAC), consisting of physicians with HZ expertise.","timeFrame":"From Month 0 until the cut-off date for final analysis (median follow-up was of 21 months)"}],"secondaryOutcomes":[{"measure":"Duration of 'Worst' HZ-associated Pain","description":"Duration of HZ-associated pain rated as 3 or greater on the 'worst pain' Zoster Brief Pain Inventory (ZBPI) question, following the onset of a confirmed HZ rash over the entire pain reporting period in subjects with confirmed HZ; presented as T (day) \\[=the sum of follow-up period (for subjects without severe worst pain T is 1, for subjects with severe worst pain T is the duration of severe worst pain) expressed in days\\].","timeFrame":"From Month 0 until study end (4 years approximately), from the onset of a confirmed HZ rash over the entire pain reporting period"},{"measure":"Number of Subjects With Confirmed HZ-associated Complications","description":"This analysis excluded complications that were linked to a confirmed HZ case that occurred after the start of the relapse treatment.","timeFrame":"From Month 0 until the cut-off date for final analysis (median follow-up was of 21 months)"},{"measure":"Number of Subjects With Postherpetic Neuralgia (PHN)","description":"This analysis excluded PHN episodes that were linked to a confirmed HZ case that occurred after the start of the relapse treatment.","timeFrame":"From Month 0 until study end (21 months median follow-up)"},{"measure":"Antigen-glycoprotein E (gE) Antibody Concentrations in a Sub-cohort of Subjects","description":"Anti-gE antibody concentrations were determined by enzyme-linked immunosorbent assay (ELISA), presented as geometric mean concentrations (GMCs) and expressed in milli-international units per milliliter (mIU/mL). The seropositivity cut-off value was greater than or equal to (≥) 97 mIU/mL.","timeFrame":"At Months 0, 1, 2, 13 and 25"},{"measure":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms","description":"Assessed solicited local symptoms were pain, redness and swelling. Any = occurrence of the symptom regardless of intensity grade. Grade 3 pain = pain that prevented normal activity. Grade 3 redness/swelling = redness/swelling spreading beyond 100 millimeters (mm) of injection site.","timeFrame":"During the 7-day (Days 0-6) post-vaccination period following each dose and across doses"},{"measure":"Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms","description":"Assessed solicited general symptoms were fatigue, gastrointestinal symptoms, headache, myalgia, shivering and fever \\[defined as axillary/tympanic temperature equal to or above 37.5 degrees Celsius (°C) or rectal temperature equal to or above 38.0 °C\\]. Any = occurrence of the symptom regardless of intensity grade. Grade 3 symptom = symptom that prevented normal activity. Grade 3 fever = fever \\> 39.5 °C. Related = symptom assessed by the investigator as related to the vaccination.","timeFrame":"During the 7-day (Days 0-6) post-vaccination period following each dose and across doses"},{"measure":"Number of Subjects With Any, Grade 3 and Related Unsolicited Adverse Events (AEs)","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination. Grade 3 AE = an AE which prevented normal, everyday activities. Related = AE assessed by the investigator as related to the vaccination.","timeFrame":"During the 30-day (Days 0-29) post-vaccination period"},{"measure":"Number of Subjects With Any and Related Potential Immune Mediated Diseases (pIMDs)","description":"Potential immune-mediated diseases (pIMDs) are a subset of AEs that include autoimmune diseases and other inflammatory and/or neurologic disorders of interest which may or may not have an autoimmune aetiology.","timeFrame":"From Month 0 up to 365 days post last vaccination"},{"measure":"Number of Subjects With Any Relapse","description":"Relapse was defined as the occurrence of the underlying malignancy or disease for which the HCT was undertaken.","timeFrame":"From Month 0 until study end (approximate median of 29 months follow-up - minimum 1 year and maximum 4 years)"},{"measure":"Number of Subjects With Any Serious Adverse Events (SAEs) and Related SAEs to GSK Study Vaccine/Placebo","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization, result in disability/incapacity or is a congenital anomaly/birth defect in the offspring of a study subject. This enpoint also presents SAES related to the GSK study vaccine/placebo.","timeFrame":"From Month 0 until 365 days post last vaccination (approximate median of 29 months follow-up - minimum 1 year and maximum 4 years)"},{"measure":"Number of Subjects With Fatal SAEs and SAEs Related to Study Participation or to a GSK Concomitant Medication or Vaccination","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization, result in disability/incapacity or is a congenital anomaly/birth defect in the offspring of a study subject. This endpoint presents fatal SAEs and SAEs related to study participation or to a concurrent GSK medication/vaccine.","timeFrame":"From the Pre-vaccination visit (Up to 110 days prior Month 0) until study end (approximate median of 29 months follow-up minimum 1 year and maximum 4 years)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nStudy entry (enrollment) occurs at the Pre-vaccination visit.\n\n* Subjects who the investigator believes can and will comply with the requirements of the protocol.\n* Written informed consent obtained from the subject.\n* A male or female aged 18 years or older at the time of study entry.\n* Has undergone or will undergo autologous HCT within 50-70 days prior to the first vaccination with the study vaccine/placebo, and there are no plans for additional HCTs.\n* Female subjects of non-childbearing potential may be enrolled in the study. For this study population, non-childbearing potential is defined as current tubal ligation, hysterectomy, ovariectomy or post-menopause.\n\nOR Female subjects of childbearing potential may be enrolled in the study, if the subject has practiced adequate contraception for 30 days prior to vaccination with the study vaccine/placebo, and has a negative pregnancy test on the day of vaccination, and has agreed to continue adequate contraception during the entire treatment period and for 12 months after completion of the vaccination series (i.e., until Month 13).\n\nExclusion Criteria:\n\n* Use of any investigational or non-registered product other than the study vaccine within 30 days preceding the first dose of study vaccine/placebo, or planned use during the study period. However, the investigational use of a registered or non-registered product to treat the subject's underlying disease for which the HCT was undertaken, or a complication of the underlying disease, is allowed.\n* Previous vaccination against HZ or varicella within the 12 months preceding the first dose of study vaccine/placebo.\n* Planned administration during the study of a HZ vaccine other than the study vaccine.\n* Occurrence of a varicella or HZ episode by clinical history within the 12 months preceding the first dose of study vaccine/placebo.\n* History of allergic disease or reactions likely to be exacerbated by any component of the vaccine or study material and equipment.\n* Prophylactic antiviral therapy with activity against Varicella Zoster Virus (VZV) expected to last more than 6 months after transplantation.\n* Administration and/or planned administration of a vaccine not foreseen by the study protocol between HCT and 30 days after the last dose of study vaccine/placebo. However, licensed non-replicating vaccines may be administered up to 8 days prior to dose 1and/or 2, and/or at least 14 days after any dose of study vaccine/placebo.\n* HIV infection by clinical history.\n* Pregnant or lactating female.\n* Female planning to become pregnant or planning to discontinue contraceptive precautions (if of childbearing potential) before Month 13 (i.e., one year after the last dose of study vaccine/placebo).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"GSK Clinical Trials","affiliation":"GlaxoSmithKline","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"GSK Investigational Site","city":"Duarte","state":"California","zip":"91010","country":"United States","geoPoint":{"lat":34.13945,"lon":-117.97729}},{"facility":"GSK Investigational Site","city":"San Francisco","state":"California","zip":"94143","country":"United States","geoPoint":{"lat":37.77493,"lon":-122.41942}},{"facility":"GSK Investigational Site","city":"Aurora","state":"Colorado","zip":"80045","country":"United States","geoPoint":{"lat":39.72943,"lon":-104.83192}},{"facility":"GSK Investigational Site","city":"Westwood","state":"Kansas","zip":"66205","country":"United States","geoPoint":{"lat":39.04056,"lon":-94.6169}},{"facility":"GSK Investigational Site","city":"Lexington","state":"Kentucky","zip":"40536","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"GSK Investigational Site","city":"Boston","state":"Massachusetts","zip":"02111","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"GSK Investigational Site","city":"Boston","state":"Massachusetts","zip":"02114","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"GSK Investigational Site","city":"Boston","state":"Massachusetts","zip":"02115","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"GSK Investigational Site","city":"Detroit","state":"Michigan","zip":"48201","country":"United States","geoPoint":{"lat":42.33143,"lon":-83.04575}},{"facility":"GSK Investigational Site","city":"Minneota","state":"Minnesota","zip":"55455","country":"United States","geoPoint":{"lat":44.55885,"lon":-95.98559}},{"facility":"GSK Investigational Site","city":"Rochester","state":"Minnesota","zip":"55905","country":"United States","geoPoint":{"lat":44.02163,"lon":-92.4699}},{"facility":"GSK Investigational Site","city":"Hackensack","state":"New Jersey","zip":"07601","country":"United States","geoPoint":{"lat":40.88593,"lon":-74.04347}},{"facility":"GSK Investigational Site","city":"New York","state":"New York","zip":"10021","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"GSK Investigational Site","city":"Syracuse","state":"New York","zip":"13210","country":"United States","geoPoint":{"lat":43.04812,"lon":-76.14742}},{"facility":"GSK Investigational Site","city":"Chapel Hill","state":"North Carolina","zip":"27599","country":"United States","geoPoint":{"lat":35.9132,"lon":-79.05584}},{"facility":"GSK Investigational Site","city":"Durham","state":"North Carolina","zip":"27705","country":"United States","geoPoint":{"lat":35.99403,"lon":-78.89862}},{"facility":"GSK Investigational Site","city":"Cleveland","state":"Ohio","zip":"44195","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"GSK Investigational Site","city":"Philadelphia","state":"Pennsylvania","zip":"19104","country":"United States","geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"GSK Investigational Site","city":"Philadelphia","state":"Pennsylvania","zip":"19107","country":"United States","geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"GSK Investigational Site","city":"Dallas","state":"Texas","zip":"75246","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"GSK Investigational Site","city":"Seattle","state":"Washington","zip":"98108","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"GSK Investigational Site","city":"Seattle","state":"Washington","zip":"98109-1024","country":"United States","geoPoint":{"lat":47.60621,"lon":-122.33207}},{"facility":"GSK Investigational Site","city":"Marshfield","state":"Wisconsin","zip":"54449","country":"United States","geoPoint":{"lat":44.66885,"lon":-90.1718}},{"facility":"GSK Investigational Site","city":"Darlinghurst","state":"New South Wales","zip":"2010","country":"Australia","geoPoint":{"lat":-33.87939,"lon":151.21925}},{"facility":"GSK Investigational Site","city":"Waratah","state":"New South Wales","zip":"2298","country":"Australia","geoPoint":{"lat":-32.90667,"lon":151.72647}},{"facility":"GSK Investigational Site","city":"Westmead","state":"New South Wales","zip":"2145","country":"Australia","geoPoint":{"lat":-33.80383,"lon":150.98768}},{"facility":"GSK Investigational Site","city":"Woodville","state":"South Australia","zip":"5011","country":"Australia","geoPoint":{"lat":-34.877,"lon":138.54291}},{"facility":"GSK Investigational Site","city":"Hobart","state":"Tasmania","zip":"7000","country":"Australia","geoPoint":{"lat":-42.87936,"lon":147.32941}},{"facility":"GSK Investigational Site","city":"Box Hill","state":"Victoria","zip":"3128","country":"Australia","geoPoint":{"lat":-37.81887,"lon":145.12545}},{"facility":"GSK Investigational Site","city":"East Melbourne","state":"Victoria","zip":"3002","country":"Australia","geoPoint":{"lat":-37.81667,"lon":144.9879}},{"facility":"GSK Investigational Site","city":"Heidelberg","state":"Victoria","zip":"3084","country":"Australia","geoPoint":{"lat":-37.75,"lon":145.06667}},{"facility":"GSK Investigational Site","city":"Parkville","state":"Victoria","zip":"3050","country":"Australia","geoPoint":{"lat":-37.78333,"lon":144.95}},{"facility":"GSK Investigational Site","city":"Antwerp","zip":"2060","country":"Belgium","geoPoint":{"lat":51.22047,"lon":4.40026}},{"facility":"GSK Investigational Site","city":"Bruges","zip":"8000","country":"Belgium","geoPoint":{"lat":51.20892,"lon":3.22424}},{"facility":"GSK Investigational Site","city":"Brussels","zip":"1000","country":"Belgium","geoPoint":{"lat":50.85045,"lon":4.34878}},{"facility":"GSK Investigational Site","city":"Ghent","zip":"9000","country":"Belgium","geoPoint":{"lat":51.05,"lon":3.71667}},{"facility":"GSK Investigational Site","city":"Hasselt","zip":"3500","country":"Belgium","geoPoint":{"lat":50.93106,"lon":5.33781}},{"facility":"GSK Investigational Site","city":"Jette","zip":"1090","country":"Belgium","geoPoint":{"lat":50.87309,"lon":4.33419}},{"facility":"GSK Investigational Site","city":"Leuven","zip":"3000","country":"Belgium","geoPoint":{"lat":50.87959,"lon":4.70093}},{"facility":"GSK Investigational Site","city":"Liège","zip":"4000","country":"Belgium","geoPoint":{"lat":50.63373,"lon":5.56749}},{"facility":"GSK Investigational Site","city":"Sofia","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"GSK Investigational Site","city":"Vancouver","state":"British Columbia","zip":"V5Z 1M9","country":"Canada","geoPoint":{"lat":49.24966,"lon":-123.11934}},{"facility":"GSK Investigational Site","city":"Saint John","state":"New Brunswick","zip":"E2L 4L2","country":"Canada","geoPoint":{"lat":45.27076,"lon":-66.05616}},{"facility":"GSK Investigational Site","city":"Toronto","state":"Ontario","zip":"M5G 2M9","country":"Canada","geoPoint":{"lat":43.65333,"lon":-79.38389}},{"facility":"GSK Investigational Site","city":"Montreal","state":"Quebec","zip":"H2L 4M1","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"GSK Investigational Site","city":"Québec","state":"Quebec","zip":"G1J 1Z4","country":"Canada","geoPoint":{"lat":46.81228,"lon":-71.21454}},{"facility":"GSK Investigational Site","city":"Saskatoon","state":"Saskatchewan","zip":"S7N 4H4","country":"Canada","geoPoint":{"lat":52.13238,"lon":-106.66892}},{"facility":"GSK Investigational Site","city":"Hradec Králové","country":"Czechia","geoPoint":{"lat":50.20923,"lon":15.83277}},{"facility":"GSK Investigational Site","city":"Olomouc","zip":"775 20","country":"Czechia","geoPoint":{"lat":49.59552,"lon":17.25175}},{"facility":"GSK Investigational Site","city":"Prague","zip":"100 34","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Prague","zip":"128 08","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"GSK Investigational Site","city":"Tallinn","zip":"13419","country":"Estonia","geoPoint":{"lat":59.43696,"lon":24.75353}},{"facility":"GSK Investigational Site","city":"Helsinki","zip":"00029","country":"Finland","geoPoint":{"lat":60.16952,"lon":24.93545}},{"facility":"GSK Investigational Site","city":"Tampere","zip":"33520","country":"Finland","geoPoint":{"lat":61.49911,"lon":23.78712}},{"facility":"GSK Investigational Site","city":"Turku","zip":"20520","country":"Finland","geoPoint":{"lat":60.45148,"lon":22.26869}},{"facility":"GSK Investigational Site","city":"Clermont-Ferrand","zip":"63003","country":"France","geoPoint":{"lat":45.77969,"lon":3.08682}},{"facility":"GSK Investigational Site","city":"Créteil","zip":"94010","country":"France","geoPoint":{"lat":48.79266,"lon":2.46569}},{"facility":"GSK Investigational Site","city":"Grenoble","zip":"38043","country":"France","geoPoint":{"lat":45.17869,"lon":5.71479}},{"facility":"GSK Investigational Site","city":"Marseille","zip":"13273","country":"France","geoPoint":{"lat":43.29695,"lon":5.38107}},{"facility":"GSK Investigational Site","city":"Montpellier","zip":"34295","country":"France","geoPoint":{"lat":43.61093,"lon":3.87635}},{"facility":"GSK Investigational Site","city":"Pessac","zip":"33604","country":"France","geoPoint":{"lat":44.80565,"lon":-0.6324}},{"facility":"GSK Investigational Site","city":"Rouen","zip":"76038","country":"France","geoPoint":{"lat":49.44313,"lon":1.09932}},{"facility":"GSK Investigational Site","city":"Heidelberg","state":"Baden-Wurttemberg","zip":"69120","country":"Germany","geoPoint":{"lat":49.40768,"lon":8.69079}},{"facility":"GSK Investigational Site","city":"Mannheim","state":"Baden-Wurttemberg","zip":"68167","country":"Germany","geoPoint":{"lat":49.4891,"lon":8.46694}},{"facility":"GSK Investigational Site","city":"Bayreuth","state":"Bavaria","zip":"95445","country":"Germany","geoPoint":{"lat":49.94782,"lon":11.57893}},{"facility":"GSK Investigational Site","city":"Munich","state":"Bavaria","zip":"81545","country":"Germany","geoPoint":{"lat":48.13743,"lon":11.57549}},{"facility":"GSK Investigational Site","city":"Würzburg","state":"Bavaria","zip":"97080","country":"Germany","geoPoint":{"lat":49.79391,"lon":9.95121}},{"facility":"GSK Investigational Site","city":"Bonn","state":"North Rhine-Westphalia","zip":"53127","country":"Germany","geoPoint":{"lat":50.73438,"lon":7.09549}},{"facility":"GSK Investigational Site","city":"Eschweiler","state":"North Rhine-Westphalia","zip":"52249","country":"Germany","geoPoint":{"lat":50.81854,"lon":6.27184}},{"facility":"GSK Investigational Site","city":"Münster","state":"North Rhine-Westphalia","zip":"48149","country":"Germany","geoPoint":{"lat":51.96236,"lon":7.62571}},{"facility":"GSK Investigational Site","city":"Velbert","state":"North Rhine-Westphalia","zip":"42551","country":"Germany","geoPoint":{"lat":51.33537,"lon":7.04348}},{"facility":"GSK Investigational Site","city":"Kiel","state":"Schleswig-Holstein","zip":"24105","country":"Germany","geoPoint":{"lat":54.32133,"lon":10.13489}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"10117","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"12200","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Berlin","zip":"12351","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"GSK Investigational Site","city":"Athens","zip":"106 76","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Athens","zip":"115 27","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Athens","zip":"11527","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Athens","zip":"151 23","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"57010","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Hong Kong","country":"Hong Kong","geoPoint":{"lat":22.27832,"lon":114.17469}},{"facility":"GSK Investigational Site","city":"Tuenmen","country":"Hong Kong","geoPoint":{"lat":22.39175,"lon":113.97157}},{"facility":"GSK Investigational Site","city":"Hafia","zip":"31096","country":"Israel"},{"facility":"GSK Investigational Site","city":"Jerusalem","zip":"91120","country":"Israel","geoPoint":{"lat":31.76904,"lon":35.21633}},{"facility":"GSK Investigational Site","city":"Cona (FE)","state":"Emilia-Romagna","zip":"44124","country":"Italy","geoPoint":{"lat":44.80583,"lon":11.7069}},{"facility":"GSK Investigational Site","city":"Meldola (FC)","state":"Emilia-Romagna","zip":"47014","country":"Italy","geoPoint":{"lat":44.12775,"lon":12.0626}},{"facility":"GSK Investigational Site","city":"Ravenna","state":"Emilia-Romagna","country":"Italy","geoPoint":{"lat":44.41344,"lon":12.20121}},{"facility":"GSK Investigational Site","city":"Rimini","state":"Emilia-Romagna","zip":"47900","country":"Italy","geoPoint":{"lat":44.05755,"lon":12.56528}},{"facility":"GSK Investigational Site","city":"Aviano (PN)","state":"Friuli Venezia Giulia","zip":"33081","country":"Italy","geoPoint":{"lat":46.07056,"lon":12.59472}},{"facility":"GSK Investigational Site","city":"Udine","state":"Friuli Venezia Giulia","zip":"33100","country":"Italy","geoPoint":{"lat":46.0693,"lon":13.23715}},{"facility":"GSK Investigational Site","city":"Rozzano (MI)","state":"Lombardy","zip":"20089","country":"Italy","geoPoint":{"lat":45.38193,"lon":9.1559}},{"facility":"GSK Investigational Site","city":"Novara","state":"Piedmont","zip":"28100","country":"Italy","geoPoint":{"lat":45.44694,"lon":8.62118}},{"facility":"GSK Investigational Site","city":"Fukuoka","zip":"811-1395","country":"Japan","geoPoint":{"lat":33.6,"lon":130.41667}},{"facility":"GSK Investigational Site","city":"Gunma","zip":"377-0280","country":"Japan"},{"facility":"GSK Investigational Site","city":"Hiroshima","zip":"737-0023","country":"Japan","geoPoint":{"lat":34.4,"lon":132.45}},{"facility":"GSK Investigational Site","city":"Hiroshima","zip":"739-0651","country":"Japan","geoPoint":{"lat":34.4,"lon":132.45}},{"facility":"GSK Investigational Site","city":"Hyōgo","zip":"650-0047","country":"Japan","geoPoint":{"lat":43.36667,"lon":144.43333}},{"facility":"GSK Investigational Site","city":"Kumamoto","zip":"860-0008","country":"Japan","geoPoint":{"lat":32.80589,"lon":130.69181}},{"facility":"GSK Investigational Site","city":"Nagasaki","zip":"856-8562","country":"Japan","geoPoint":{"lat":32.75,"lon":129.88333}},{"facility":"GSK Investigational Site","city":"Niigata","zip":"951-8566","country":"Japan","geoPoint":{"lat":37.92259,"lon":139.04125}},{"facility":"GSK Investigational Site","city":"Okayama","zip":"700-8558","country":"Japan","geoPoint":{"lat":34.65,"lon":133.93333}},{"facility":"GSK Investigational Site","city":"Okayama","zip":"701-1192","country":"Japan","geoPoint":{"lat":34.65,"lon":133.93333}},{"facility":"GSK Investigational Site","city":"Shizuoka","zip":"411-8777","country":"Japan","geoPoint":{"lat":34.98333,"lon":138.38333}},{"facility":"GSK Investigational Site","city":"Tokyo","zip":"113-8677","country":"Japan","geoPoint":{"lat":35.6895,"lon":139.69171}},{"facility":"GSK Investigational Site","city":"Kuala Lumpur","zip":"56000","country":"Malaysia","geoPoint":{"lat":3.1412,"lon":101.68653}},{"facility":"GSK Investigational Site","city":"Kuala Selangor","zip":"68000 Ampang","country":"Malaysia","geoPoint":{"lat":3.35,"lon":101.25}},{"facility":"GSK Investigational Site","city":"Leiden","zip":"2333 ZA","country":"Netherlands","geoPoint":{"lat":52.15833,"lon":4.49306}},{"facility":"GSK Investigational Site","city":"Christchurch","zip":"8011","country":"New Zealand","geoPoint":{"lat":-43.53333,"lon":172.63333}},{"facility":"GSK Investigational Site","city":"Grafton","zip":"1003","country":"New Zealand","geoPoint":{"lat":-36.86029,"lon":174.76566}},{"facility":"GSK Investigational Site","city":"Wellington","zip":"6021","country":"New Zealand","geoPoint":{"lat":-41.28664,"lon":174.77557}},{"facility":"GSK Investigational Site","city":"Panama City","country":"Panama","geoPoint":{"lat":8.9936,"lon":-79.51973}},{"facility":"GSK Investigational Site","city":"Gliwice","zip":"44-101","country":"Poland","geoPoint":{"lat":50.29761,"lon":18.67658}},{"facility":"GSK Investigational Site","city":"Krakow","zip":"30510","country":"Poland","geoPoint":{"lat":50.06143,"lon":19.93658}},{"facility":"GSK Investigational Site","city":"Warsaw","zip":"02-776","country":"Poland","geoPoint":{"lat":52.22977,"lon":21.01178}},{"facility":"GSK Investigational Site","city":"Bucharest","zip":"022328","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"GSK Investigational Site","city":"Bucharest","zip":"030171","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"GSK Investigational Site","city":"Târgu Mureş","zip":"540042","country":"Romania","geoPoint":{"lat":46.54245,"lon":24.55747}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"105 229","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Moscow","zip":"125101","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"GSK Investigational Site","city":"Novosibirsk","zip":"630099","country":"Russia","geoPoint":{"lat":55.02259,"lon":82.93175}},{"facility":"GSK Investigational Site","city":"Petrozavodsk","zip":"185019","country":"Russia","geoPoint":{"lat":61.78491,"lon":34.34691}},{"facility":"GSK Investigational Site","city":"Saint Petersburg","zip":"194291","country":"Russia","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"GSK Investigational Site","city":"Saint Petersburg","zip":"197110","country":"Russia","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"GSK Investigational Site","city":"St'Petersburg","zip":"191024","country":"Russia"},{"facility":"GSK Investigational Site","city":"Parktown","state":"Gauteng","zip":"2193","country":"South Africa","geoPoint":{"lat":-26.18205,"lon":28.02671}},{"facility":"GSK Investigational Site","city":"Plumstead","state":"Western Province","country":"South Africa","geoPoint":{"lat":-34.01909,"lon":18.47835}},{"facility":"GSK Investigational Site","city":"Groenkloof","zip":"0181","country":"South Africa","geoPoint":{"lat":-31.78089,"lon":25.50906}},{"facility":"GSK Investigational Site","city":"Moreleta Park, Pretoria","zip":"0001","country":"South Africa"},{"facility":"GSK Investigational Site","city":"Daegu","zip":"700-721","country":"South Korea","geoPoint":{"lat":35.87102,"lon":128.60121}},{"facility":"GSK Investigational Site","city":"Incheon","zip":"405-760","country":"South Korea","geoPoint":{"lat":37.45646,"lon":126.70515}},{"facility":"GSK Investigational Site","city":"Jellanamdo","zip":"519-809","country":"South Korea"},{"facility":"GSK Investigational Site","city":"Jeonju","zip":"561-712","country":"South Korea","geoPoint":{"lat":35.82483,"lon":127.14796}},{"facility":"GSK Investigational Site","city":"Kyunggi-do","zip":"410-769","country":"South Korea"},{"facility":"GSK Investigational Site","city":"Seoul","zip":"110-744","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"120-752","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"135-710","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"Seoul","zip":"137-701","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"GSK Investigational Site","city":"A Coruña","zip":"15006","country":"Spain","geoPoint":{"lat":43.37135,"lon":-8.396}},{"facility":"GSK Investigational Site","city":"Badalona/Barcelona","zip":"08916","country":"Spain"},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08025","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08035","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"Barcelona","zip":"08036","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"GSK Investigational Site","city":"León","zip":"24008","country":"Spain","geoPoint":{"lat":42.60003,"lon":-5.57032}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28009","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28033","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28034","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28040","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28041","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28050","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28911","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Madrid","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Majadahonda (Madrid)","zip":"28222","country":"Spain","geoPoint":{"lat":40.47353,"lon":-3.87182}},{"facility":"GSK Investigational Site","city":"Málaga","zip":"29010","country":"Spain","geoPoint":{"lat":36.72016,"lon":-4.42034}},{"facility":"GSK Investigational Site","city":"Murcia","zip":"30008","country":"Spain","geoPoint":{"lat":37.98704,"lon":-1.13004}},{"facility":"GSK Investigational Site","city":"Murcia (El Palmar)","zip":"30120","country":"Spain","geoPoint":{"lat":37.98704,"lon":-1.13004}},{"facility":"GSK Investigational Site","city":"Oviedo","zip":"33006","country":"Spain","geoPoint":{"lat":43.36029,"lon":-5.84476}},{"facility":"GSK Investigational Site","city":"Pozuelo de Alarcón/Madrid","zip":"28223","country":"Spain"},{"facility":"GSK Investigational Site","city":"San Sebastián","zip":"20014","country":"Spain","geoPoint":{"lat":43.56667,"lon":-5.9}},{"facility":"GSK Investigational Site","city":"Santander","zip":"39008","country":"Spain","geoPoint":{"lat":43.46589,"lon":-3.80493}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46010","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46026","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Kaohsiung City","zip":"833","country":"Taiwan","geoPoint":{"lat":22.61626,"lon":120.31333}},{"facility":"GSK Investigational Site","city":"Taichung","zip":"404","country":"Taiwan","geoPoint":{"lat":24.1469,"lon":120.6839}},{"facility":"GSK Investigational Site","city":"Taichung","zip":"40705","country":"Taiwan","geoPoint":{"lat":24.1469,"lon":120.6839}},{"facility":"GSK Investigational Site","city":"Taoyuan Hsien","zip":"333","country":"Taiwan"},{"facility":"GSK Investigational Site","city":"Ankara","zip":"06100","country":"Turkey (Türkiye)","geoPoint":{"lat":39.91987,"lon":32.85427}},{"facility":"GSK Investigational Site","city":"Ankara","zip":"06500","country":"Turkey (Türkiye)","geoPoint":{"lat":39.91987,"lon":32.85427}},{"facility":"GSK Investigational Site","city":"Ankara","country":"Turkey (Türkiye)","geoPoint":{"lat":39.91987,"lon":32.85427}},{"facility":"GSK Investigational Site","city":"Istanbul","zip":"34481","country":"Turkey (Türkiye)","geoPoint":{"lat":41.01384,"lon":28.94966}},{"facility":"GSK Investigational Site","city":"Izmir","country":"Turkey (Türkiye)","geoPoint":{"lat":38.41273,"lon":27.13838}},{"facility":"GSK Investigational Site","city":"Airdrie","state":"Lanarkshire","zip":"ML6 0JS","country":"United Kingdom","geoPoint":{"lat":55.86602,"lon":-3.98025}},{"facility":"GSK Investigational Site","city":"Swindon","state":"Wiltshire","zip":"SN3 6BB","country":"United Kingdom","geoPoint":{"lat":51.55797,"lon":-1.78116}},{"facility":"GSK Investigational Site","city":"Bournemouth","zip":"BH7 7DW","country":"United Kingdom","geoPoint":{"lat":50.72048,"lon":-1.8795}},{"facility":"GSK Investigational Site","city":"Cottingham","zip":"HU16 5JQ","country":"United Kingdom","geoPoint":{"lat":52.50243,"lon":-0.7554}},{"facility":"GSK Investigational Site","city":"Headington, Oxford","zip":"OX3 7LE","country":"United Kingdom"},{"facility":"GSK Investigational Site","city":"Leeds","zip":"LS9 7TF","country":"United Kingdom","geoPoint":{"lat":53.79648,"lon":-1.54785}},{"facility":"GSK Investigational Site","city":"Manchester","zip":"M13 9WL","country":"United Kingdom","geoPoint":{"lat":53.48095,"lon":-2.23743}},{"facility":"GSK Investigational Site","city":"Manchester","zip":"M20 4BX","country":"United Kingdom","geoPoint":{"lat":53.48095,"lon":-2.23743}}]},"referencesModule":{"references":[{"pmid":"37166199","type":"DERIVED","citation":"Matthews S, Curran D, Sabater Cabrera E, Boutry C, Lecrenier N, Cunningham AL, Schmader K. An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies. Clin J Pain. 2023 Aug 1;39(8):386-393. doi: 10.1097/AJP.0000000000001129."},{"pmid":"36066965","type":"DERIVED","citation":"Kim JH, Johnson R, Kovac M, Cunningham AL, Amakrane M, Sullivan KM, Dagnew AF, Curran D, Schuind A. Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials. Pain. 2023 Apr 1;164(4):741-748. doi: 10.1097/j.pain.0000000000002760. Epub 2022 Aug 19."},{"pmid":"31394276","type":"DERIVED","citation":"Curran D, Matthews S, Rowley SD, Young JH, Bastidas A, Anagnostopoulos A, Barista I, Chandrasekar PH, Dickinson M, El Idrissi M, Heras I, Milliken ST, Monserrat Coll J, Navarro Matilla MB, Oostvogels L, Piatkowska-Jakubas B, Quiel D, Sabry W, Schwartz S, Selleslag DLD, Sullivan KM, Theunissen K, Yegin ZA, Yeh SP, Zaja F, Szer J; ZOE-HSCT Study group collaborators. Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT). Biol Blood Marrow Transplant. 2019 Dec;25(12):2474-2481. doi: 10.1016/j.bbmt.2019.07.036. Epub 2019 Aug 5."},{"pmid":"31287523","type":"DERIVED","citation":"Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, Lopez-Jimenez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM; ZOE-HSCT Study Group Collaborators. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. JAMA. 2019 Jul 9;322(2):123-133. doi: 10.1001/jama.2019.9053."}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Some of the enrolled subjects were allocated subject numbers, but were not administered all doses of study vaccine, hence they did not start the study.","groups":[{"id":"FG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"FG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"periods":[{"title":"Study Start - Month 13","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"922"},{"groupId":"FG001","numSubjects":"924"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"807"},{"groupId":"FG001","numSubjects":"795"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"115"},{"groupId":"FG001","numSubjects":"129"}]}],"dropWithdraws":[{"type":"Serious Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"65"},{"groupId":"FG001","numSubjects":"67"}]},{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"14"},{"groupId":"FG001","numSubjects":"14"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"1"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"23"},{"groupId":"FG001","numSubjects":"30"}]},{"type":"Migrated/moved from study area","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"4"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"6"}]},{"type":"Suspected HZ episode","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"3"}]},{"type":"Other reasons for withdrawal","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"4"}]}]},{"title":"Month 13 - Month 25","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"922"},{"groupId":"FG001","numSubjects":"924"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"857"},{"groupId":"FG001","numSubjects":"854"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"65"},{"groupId":"FG001","numSubjects":"70"}]}],"dropWithdraws":[{"type":"Serious Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"35"},{"groupId":"FG001","numSubjects":"38"}]},{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"4"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"8"}]},{"type":"Migrated/moved from study area","reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"2"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"9"}]},{"type":"Other reasons for withdrawal","reasons":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"7"}]}]},{"title":"After Month 25","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"922"},{"groupId":"FG001","numSubjects":"924"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"874"},{"groupId":"FG001","numSubjects":"871"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"53"}]}],"dropWithdraws":[{"type":"Study end not reached","reasons":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"53"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"BG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"922"},{"groupId":"BG001","value":"924"},{"groupId":"BG002","value":"1846"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"54.8","spread":"11.7"},{"groupId":"BG001","value":"55.1","spread":"11.4"},{"groupId":"BG002","value":"55.0","spread":"11.6"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"342"},{"groupId":"BG001","value":"346"},{"groupId":"BG002","value":"688"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"580"},{"groupId":"BG001","value":"578"},{"groupId":"BG002","value":"1158"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Geographic ancestry","categories":[{"title":"African Heritage/African American","measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"40"}]},{"title":"American Indian or Alaskan Native","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}]},{"title":"Asian - Central/South Asian Heritage","measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"11"}]},{"title":"Asian - East Asian Heritage","measurements":[{"groupId":"BG000","value":"83"},{"groupId":"BG001","value":"91"},{"groupId":"BG002","value":"174"}]},{"title":"Asian - Japanese Heritage","measurements":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"38"},{"groupId":"BG002","value":"81"}]},{"title":"Asian - South East Asian Heritage","measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"34"}]},{"title":"White - Arabic/North African Heritage","measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"21"}]},{"title":"White - Caucasian/European Heritage","measurements":[{"groupId":"BG000","value":"715"},{"groupId":"BG001","value":"712"},{"groupId":"BG002","value":"1427"}]},{"title":"Mixed Origin","measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"56"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With Confirmed Herpes Zoster (HZ) Episode","description":"A suspected case of HZ was defined as (1) a new rash characteristic of HZ (e.g., unilateral, dermatomal and accompanied by pain broadly defined to include allodynia, pruritus or other sensations), or a vesicular rash suggestive of VZV infection regardless of the distribution, and no alternative diagnosis; or (2) a clinical presentation (symptoms and/or signs) and specific laboratory findings\\* suggestive of VZV infection in the absence of characteristic HZ or VZV rash.\n\nA suspected case of HZ was confirmed either: by Polymerase Chain Reaction (PCR) or by the HZ Ascertainment Committee (HZAC), consisting of physicians with HZ expertise.","populationDescription":"The analysis was performed on the modified Total Vaccinated Cohort, which excluded subjects from the Total Vaccinated Cohort analysis who were not administered with the second vaccination or who received vaccine doses/or replacement not on the same group or who developed a confirmed case of HZ prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 until the cut-off date for final analysis (median follow-up was of 21 months)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"870"},{"groupId":"OG001","value":"851"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"135"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Vaccine efficacy (VE) was evaluated in the prevention of Herpes Zoster (HZ) in autologous haematopoietic stem cell transplant (HCT) recipients 18 years of agee and older.","nonInferiorityType":"SUPERIORITY","nonInferiorityComment":"Criterion: The lower limit (LL) of the 95% confidence interval (CI) for overall HZ vaccine efficacy was above 0%.","pValue":"<0.0001","statisticalMethod":"Poisson method","paramType":"Vaccine efficacy","paramValue":"68.17","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"55.56","ciUpperLimit":"77.53"}]},{"type":"SECONDARY","title":"Duration of 'Worst' HZ-associated Pain","description":"Duration of HZ-associated pain rated as 3 or greater on the 'worst pain' Zoster Brief Pain Inventory (ZBPI) question, following the onset of a confirmed HZ rash over the entire pain reporting period in subjects with confirmed HZ; presented as T (day) \\[=the sum of follow-up period (for subjects without severe worst pain T is 1, for subjects with severe worst pain T is the duration of severe worst pain) expressed in days\\].","populationDescription":"The analysis was performed on the modified Total Vaccinated Cohort, which excluded subjects from the Total Vaccinated Cohort analysis, who developed a confirmed case of HZ prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"T (day)","timeFrame":"From Month 0 until study end (4 years approximately), from the onset of a confirmed HZ rash over the entire pain reporting period","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"135"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"892.0"},{"groupId":"OG001","value":"6275.0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Confirmed HZ-associated Complications","description":"This analysis excluded complications that were linked to a confirmed HZ case that occurred after the start of the relapse treatment.","populationDescription":"The analysis was performed on the modified Total Vaccinated Cohort, which excluded subjects from the Total Vaccinated Cohort analysis who were not administered with the second vaccination or who received vaccine doses/or replacement not on the same group or who developed a confirmed case of HZ prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 until the cut-off date for final analysis (median follow-up was of 21 months)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"870"},{"groupId":"OG001","value":"851"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"13"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Postherpetic Neuralgia (PHN)","description":"This analysis excluded PHN episodes that were linked to a confirmed HZ case that occurred after the start of the relapse treatment.","populationDescription":"The analysis was performed on the modified Total Vaccinated Cohort, which excluded subjects from the Total Vaccinated Cohort analysis who were not administered with the second vaccination or who received vaccine doses/or replacement not on the same group or who developed a confirmed case of HZ prior to 1 month after the second vaccination.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 until study end (21 months median follow-up)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"870"},{"groupId":"OG001","value":"851"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"9"}]}]}]},{"type":"SECONDARY","title":"Antigen-glycoprotein E (gE) Antibody Concentrations in a Sub-cohort of Subjects","description":"Anti-gE antibody concentrations were determined by enzyme-linked immunosorbent assay (ELISA), presented as geometric mean concentrations (GMCs) and expressed in milli-international units per milliliter (mIU/mL). The seropositivity cut-off value was greater than or equal to (≥) 97 mIU/mL.","populationDescription":"The analysis was performed on the adapted According-to-Protocol (ATP) cohort for humoral immunogenicity, which included data from the ATP cohorts for humoral immunogenicity at Months 0,1,2,13 and 25. The ATP cohort for humoral immunogenicity included all subjects from humoral immunogenicity sub-cohort in ATP cohort for analysis of immunogenicity.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"mIU/mL","timeFrame":"At Months 0, 1, 2, 13 and 25","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"76"}]}],"classes":[{"title":"Anti-gE, Month 0","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"76"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"762.8","lowerLimit":"568.6","upperLimit":"1023.5"},{"groupId":"OG001","value":"555.0","lowerLimit":"404.3","upperLimit":"761.8"}]}]},{"title":"Anti-gE, Month 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"78"},{"groupId":"OG001","value":"71"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1844.2","lowerLimit":"1282.2","upperLimit":"2652.4"},{"groupId":"OG001","value":"556.6","lowerLimit":"407.3","upperLimit":"760.6"}]}]},{"title":"Anti-gE, Month 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"76"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12753.2","lowerLimit":"7973.0","upperLimit":"20399.4"},{"groupId":"OG001","value":"443.8","lowerLimit":"330.8","upperLimit":"595.4"}]}]},{"title":"Anti-gE, Month 13","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"45"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3183.8","lowerLimit":"1869.8","upperLimit":"5421.2"},{"groupId":"OG001","value":"503.6","lowerLimit":"307.8","upperLimit":"824.1"}]}]},{"title":"Anti-gE, Month 25","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"28"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2819.0","lowerLimit":"1387.1","upperLimit":"5729.1"},{"groupId":"OG001","value":"527.0","lowerLimit":"274.3","upperLimit":"1012.6"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms","description":"Assessed solicited local symptoms were pain, redness and swelling. Any = occurrence of the symptom regardless of intensity grade. Grade 3 pain = pain that prevented normal activity. Grade 3 redness/swelling = redness/swelling spreading beyond 100 millimeters (mm) of injection site.","populationDescription":"The analysis was performed on the Total Vaccinated Cohort, which included all vaccinated subjects with respect to the vaccine actually administered, who had filled in their symptom sheets.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the 7-day (Days 0-6) post-vaccination period following each dose and across doses","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"892"}]}],"classes":[{"title":"Any Pain, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"890"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"688"},{"groupId":"OG001","value":"56"}]}]},{"title":"Grade 3 Pain, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"890"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"3"}]}]},{"title":"Any Redness, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"890"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"187"},{"groupId":"OG001","value":"5"}]}]},{"title":"Grade 3 Redness, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"890"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Swelling, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"890"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"101"},{"groupId":"OG001","value":"7"}]}]},{"title":"Grade 3 Swelling, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"890"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Pain, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"840"},{"groupId":"OG001","value":"834"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"638"},{"groupId":"OG001","value":"45"}]}]},{"title":"Grade 3 Pain, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"840"},{"groupId":"OG001","value":"834"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Redness, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"840"},{"groupId":"OG001","value":"834"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"231"},{"groupId":"OG001","value":"4"}]}]},{"title":"Grade 3 Redness, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"840"},{"groupId":"OG001","value":"834"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Swelling, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"840"},{"groupId":"OG001","value":"834"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"132"},{"groupId":"OG001","value":"3"}]}]},{"title":"Grade 3 Swelling, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"840"},{"groupId":"OG001","value":"834"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Pain, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"756"},{"groupId":"OG001","value":"83"}]}]},{"title":"Grade 3 Pain, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"99"},{"groupId":"OG001","value":"3"}]}]},{"title":"Any Redness, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"301"},{"groupId":"OG001","value":"9"}]}]},{"title":"Grade 3 Redness, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"0"}]}]},{"title":"Any Swelling, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"168"},{"groupId":"OG001","value":"9"}]}]},{"title":"Grade 3 Swelling, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms","description":"Assessed solicited general symptoms were fatigue, gastrointestinal symptoms, headache, myalgia, shivering and fever \\[defined as axillary/tympanic temperature equal to or above 37.5 degrees Celsius (°C) or rectal temperature equal to or above 38.0 °C\\]. Any = occurrence of the symptom regardless of intensity grade. Grade 3 symptom = symptom that prevented normal activity. Grade 3 fever = fever \\> 39.5 °C. Related = symptom assessed by the investigator as related to the vaccination.","populationDescription":"The analysis was performed on the Total Vaccinated Cohort, which included all vaccinated subjects with respect to the vaccine actually administered, who had filled in their symptom sheets.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the 7-day (Days 0-6) post-vaccination period following each dose and across doses","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"classes":[{"title":"Any Fatigue, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"356"},{"groupId":"OG001","value":"282"}]}]},{"title":"Grade 3 Fatigue, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"16"}]}]},{"title":"Related Fatigue, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"124"},{"groupId":"OG001","value":"55"}]}]},{"title":"Any Gastrointestinal, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"150"},{"groupId":"OG001","value":"134"}]}]},{"title":"Grade 3 Gastrointestinal, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"7"}]}]},{"title":"Related Gastrointestinal, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"22"}]}]},{"title":"Any Headache, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"156"},{"groupId":"OG001","value":"121"}]}]},{"title":"Grade 3 Headache, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"}]}]},{"title":"Related Headache, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"32"}]}]},{"title":"Any Myalgia, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"340"},{"groupId":"OG001","value":"170"}]}]},{"title":"Grade 3 Myalgia, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"11"}]}]},{"title":"Related Myalgia, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"170"},{"groupId":"OG001","value":"50"}]}]},{"title":"Any Shivering, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"116"},{"groupId":"OG001","value":"73"}]}]},{"title":"Grade 3 Shivering, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"}]}]},{"title":"Related Shivering, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"27"}]}]},{"title":"Any Temperature, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"28"}]}]},{"title":"Grade 3 Temperature, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]},{"title":"Related Temperature, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"896"},{"groupId":"OG001","value":"892"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"7"}]}]},{"title":"Any Fatigue, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"395"},{"groupId":"OG001","value":"212"}]}]},{"title":"Grade 3 Fatigue, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"20"}]}]},{"title":"Related Fatigue, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"153"},{"groupId":"OG001","value":"41"}]}]},{"title":"Any Gastrointestinal, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"142"},{"groupId":"OG001","value":"98"}]}]},{"title":"Grade 3 Gastrointestinal, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"12"}]}]},{"title":"Related Gastrointestinal, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"13"}]}]},{"title":"Any Headache, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"232"},{"groupId":"OG001","value":"88"}]}]},{"title":"Grade 3 Headache, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"8"}]}]},{"title":"Related Any Headache, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"95"},{"groupId":"OG001","value":"20"}]}]},{"title":"Any Myalgia, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"374"},{"groupId":"OG001","value":"153"}]}]},{"title":"Grade 3 Myalgia, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"9"}]}]},{"title":"Related Myalgia, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"208"},{"groupId":"OG001","value":"47"}]}]},{"title":"Any Shivering, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"185"},{"groupId":"OG001","value":"59"}]}]},{"title":"Grade 3 Shivering, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"1"}]}]},{"title":"Related Shivering, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"102"},{"groupId":"OG001","value":"16"}]}]},{"title":"Any Temperature, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"150"},{"groupId":"OG001","value":"28"}]}]},{"title":"Grade 3 Temperature, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}]}]},{"title":"Related Temperature, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"835"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"8"}]}]},{"title":"Any Fatigue, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"508"},{"groupId":"OG001","value":"340"}]}]},{"title":"Grade 3 Fatigue, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"31"}]}]},{"title":"Related Fatigue, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"210"},{"groupId":"OG001","value":"79"}]}]},{"title":"Any Gastrointestinal, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"238"},{"groupId":"OG001","value":"183"}]}]},{"title":"Grade 3 Gastrointestinal, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"17"}]}]},{"title":"Related Gastrointestinal, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"30"}]}]},{"title":"Any Headache, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"302"},{"groupId":"OG001","value":"166"}]}]},{"title":"Grade 3 Headache, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"10"}]}]},{"title":"Related Headache, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"123"},{"groupId":"OG001","value":"46"}]}]},{"title":"Any Myalgia, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"484"},{"groupId":"OG001","value":"234"}]}]},{"title":"Grade 3 Myalgia, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"19"}]}]},{"title":"Related Myalgia, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"279"},{"groupId":"OG001","value":"83"}]}]},{"title":"Any Shivering, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"237"},{"groupId":"OG001","value":"115"}]}]},{"title":"Grade 3 Shivering, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"7"}]}]},{"title":"Related Shivering, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"131"},{"groupId":"OG001","value":"38"}]}]},{"title":"Any Temperature, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"183"},{"groupId":"OG001","value":"50"}]}]},{"title":"Grade 3 Temperature, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"}]}]},{"title":"Related Temperature, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"901"},{"groupId":"OG001","value":"894"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"101"},{"groupId":"OG001","value":"15"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any, Grade 3 and Related Unsolicited Adverse Events (AEs)","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination. Grade 3 AE = an AE which prevented normal, everyday activities. Related = AE assessed by the investigator as related to the vaccination.","populationDescription":"The analysis was performed on the Total Vaccinated Cohort, which included all vaccinated subjects with respect to the vaccine actually administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the 30-day (Days 0-29) post-vaccination period","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"922"},{"groupId":"OG001","value":"924"}]}],"classes":[{"title":"Any AE(s)","categories":[{"measurements":[{"groupId":"OG000","value":"360"},{"groupId":"OG001","value":"353"}]}]},{"title":"Grade 3 AE(s)","categories":[{"measurements":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"47"}]}]},{"title":"Related AE(s)","categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"23"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Related Potential Immune Mediated Diseases (pIMDs)","description":"Potential immune-mediated diseases (pIMDs) are a subset of AEs that include autoimmune diseases and other inflammatory and/or neurologic disorders of interest which may or may not have an autoimmune aetiology.","populationDescription":"The analysis was performed on the Total Vaccinated Cohort, which included all vaccinated subjects with respect to the vaccine actually administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 up to 365 days post last vaccination","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"922"},{"groupId":"OG001","value":"924"}]}],"classes":[{"title":"Any pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"8"}]}]},{"title":"Related pIMDs","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any Relapse","description":"Relapse was defined as the occurrence of the underlying malignancy or disease for which the HCT was undertaken.","populationDescription":"The analysis was performed on the Total Vaccinated Cohort, which included all vaccinated subjects with respect to the vaccine actually administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 until study end (approximate median of 29 months follow-up - minimum 1 year and maximum 4 years)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"922"},{"groupId":"OG001","value":"924"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"239"},{"groupId":"OG001","value":"253"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any Serious Adverse Events (SAEs) and Related SAEs to GSK Study Vaccine/Placebo","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization, result in disability/incapacity or is a congenital anomaly/birth defect in the offspring of a study subject. This enpoint also presents SAES related to the GSK study vaccine/placebo.","populationDescription":"The analysis was performed on the Total Vaccinated Cohort, which included all vaccinated subjects with respect to the vaccine actually administered.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 until 365 days post last vaccination (approximate median of 29 months follow-up - minimum 1 year and maximum 4 years)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"922"},{"groupId":"OG001","value":"924"}]}],"classes":[{"title":"Any SAEs, up to Month 13","categories":[{"measurements":[{"groupId":"OG000","value":"263"},{"groupId":"OG001","value":"241"}]}]},{"title":"Related SAEs, up to Month 13","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"4"}]}]},{"title":"Any SAEs, up to Study End","categories":[{"measurements":[{"groupId":"OG000","value":"329"},{"groupId":"OG001","value":"310"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Fatal SAEs and SAEs Related to Study Participation or to a GSK Concomitant Medication or Vaccination","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization, result in disability/incapacity or is a congenital anomaly/birth defect in the offspring of a study subject. This endpoint presents fatal SAEs and SAEs related to study participation or to a concurrent GSK medication/vaccine.","populationDescription":"The analysis was performed on the Total Enrolled Cohort.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From the Pre-vaccination visit (Up to 110 days prior Month 0) until study end (approximate median of 29 months follow-up minimum 1 year and maximum 4 years)","groups":[{"id":"OG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule."},{"id":"OG002","title":"No Group","description":"Subjects who were not assigned to any group (subjects from pre-vaccination visit)."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"932"},{"groupId":"OG001","value":"933"},{"groupId":"OG002","value":"3"}]}],"classes":[{"title":"Fatal SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"118"},{"groupId":"OG001","value":"124"},{"groupId":"OG002","value":"0"}]}]},{"title":"Related SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"43"},{"groupId":"OG002","value":"0"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Solicited local and general symptoms: during the 7-day (Days 0-6) post-vaccination period; Unsolicited adverse events (AEs): during the 30-day (Days 0-29) post-vaccination period; SAEs: during the entire study period, up to 365 days post last vaccination (4 years approximately).","eventGroups":[{"id":"EG000","title":"GSK1437173A Group","description":"Subjects received 2 doses of the candidate HZ vaccine GSK1437173A, administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule.","deathsNumAffected":118,"deathsNumAtRisk":922,"seriousNumAffected":329,"seriousNumAtRisk":922,"otherNumAffected":813,"otherNumAtRisk":922},{"id":"EG001","title":"Placebo Group","description":"Subjects received 2 doses of placebo (saline solution), administered intramuscularly (IM) in deltoid region of the non-dominant arm, according to a 0, 1-2-Months schedule.","deathsNumAffected":124,"deathsNumAtRisk":924,"seriousNumAffected":310,"seriousNumAtRisk":924,"otherNumAffected":485,"otherNumAtRisk":924}],"seriousEvents":[{"term":"Agranulocytosis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Autoimmune haemolytic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Disseminated intravascular coagulation","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Febrile neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":14,"numAtRisk":922},{"groupId":"EG001","numEvents":13,"numAffected":12,"numAtRisk":924}]},{"term":"Haemolytic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Immune thrombocytopenic purpura","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Neutropenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Normochromic normocytic anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pancytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":924}]},{"term":"Thrombocytopenia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":924}]},{"term":"Thrombotic microangiopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Atrial thrombosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cardiac amyloidosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Cardiac disorder","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cardiopulmonary failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Congestive cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Coronary artery occlusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pulseless electrical activity","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Supraventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Ventricular dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Haematotympanum","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hypoacusis","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Tympanic membrane perforation","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hyperparathyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cataract","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Diplopia","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Retinal vein occlusion","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Anal fissure","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Ascites","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Dysphagia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Enteritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Faecaloma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Gastritis erosive","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Haematochezia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Ileus paralytic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Intestinal perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Irritable bowel syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Large intestine perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Mesenteric artery thrombosis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Oesophageal achalasia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Small intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Upper gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Adverse drug reaction","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Cardiac death","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"General physical health deterioration","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Hernia","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Infusion site extravasation","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Mucosal inflammation","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Multiple organ dysfunction syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":10,"numAtRisk":922},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":924}]},{"term":"Sudden death","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Systemic inflammatory response syndrome","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Acute hepatic failure","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Bile duct obstruction","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Cholecystitis chronic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hepatic failure","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Hepatic function abnormal","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hepatitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Hepatitis cholestatic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Hepatitis toxic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Portal hypertension","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Acute graft versus host disease","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Amyloidosis","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Chronic graft versus host disease","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Graft versus host disease","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Graft versus host disease in gastrointestinal tract","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Graft versus host disease in liver","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Graft versus host disease in skin","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Aspergillus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Atypical pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":924}]},{"term":"Bacterial infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":924}]},{"term":"Bronchopulmonary aspergillosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Campylobacter gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Catheter site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":924}]},{"term":"Clostridium difficile colitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cytomegalovirus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Device related infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Endophthalmitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Epididymitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Epiglottitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Epstein-barr viraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Escherichia sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Escherichia urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Febrile infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Fungal pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Furuncle","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Gastroenteritis salmonella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Gastrointestinal viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"H1n1 influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Hepatitis b","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Hepatitis b reactivation","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Herpes simplex","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":924}]},{"term":"Herpes zoster cutaneous disseminated","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":924}]},{"term":"Herpes zoster meningitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Herpes zoster meningoencephalitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Impetigo","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":922},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":924}]},{"term":"Klebsiella bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Klebsiella infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Lower respiratory tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Lung abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Lung infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":924}]},{"term":"Meningitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Meningitis meningococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Meningitis pneumococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Meningitis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Meningoencephalitis herpetic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Mycoplasma infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Myelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Neutropenic sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Osteomyelitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Otitis media","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Otitis media chronic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Parainfluenzae virus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":924}]},{"term":"Peritonitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Pharyngeal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumococcal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Pneumocystis jirovecii pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":64,"numAffected":55,"numAtRisk":922},{"groupId":"EG001","numEvents":46,"numAffected":41,"numAtRisk":924}]},{"term":"Pneumonia bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonia fungal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonia haemophilus","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Pneumonia influenzal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonia legionella","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonia necrotising","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonia parainfluenzae viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonia pneumococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Pneumonia pseudomonal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Pneumonia staphylococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Pneumonia viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Postoperative wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Respiratory syncytial virus bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Respiratory syncytial virus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":922},{"groupId":"EG001","numEvents":11,"numAffected":10,"numAtRisk":924}]},{"term":"Respiratory tract infection bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":15,"numAffected":15,"numAtRisk":922},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":924}]},{"term":"Septic shock","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":922},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":924}]},{"term":"Serratia sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Sinusitis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Spinal cord abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Staphylococcal abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Staphylococcal scalded skin syndrome","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Staphylococcal sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Streptococcal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Femoral neck fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Foot fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Incisional hernia","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonitis chemical","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Spinal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Sternal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Subdural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Toxicity to various agents","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Transfusion reaction","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Immunoglobulins decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Liver function test abnormal","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":924}]},{"term":"Neutrophil count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Transaminases increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cachexia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Diabetes mellitus inadequate control","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hypercalcaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Hyperglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Metabolic acidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Tumour lysis syndrome","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Bone pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Kyphosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Lumbar spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pathological fracture","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Polymyalgia rheumatica","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Systemic scleroderma","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Trigger finger","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Acute leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Acute myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":922},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":924}]},{"term":"Acute promyelocytic leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Adenocarcinoma of colon","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Angiocentric lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Angioimmunoblastic t-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"B-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":922},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":924}]},{"term":"Benign breast neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Bile duct cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Burkitt's lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Central nervous system lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Diffuse large b-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":14,"numAffected":13,"numAtRisk":922},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":924}]},{"term":"Epstein-barr virus associated lymphoproliferative disorder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Ewing's sarcoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":924}]},{"term":"Gastric cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hairy cell leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hodgkin's disease","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Leiomyosarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Lipoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Lung adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":13,"numAtRisk":922},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":924}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Malignant ovarian cyst","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Mantle cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":924}]},{"term":"Marginal zone lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Mesothelioma malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Metastases to adrenals","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Metastases to central nervous system","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Metastases to meninges","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Metastatic carcinoma of the bladder","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Myeloid leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Non-hodgkin's lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":924}]},{"term":"Non-small cell lung cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Peripheral t-cell lymphoma unspecified","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Plasma cell leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Plasma cell myeloma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":95,"numAffected":90,"numAtRisk":922},{"groupId":"EG001","numEvents":71,"numAffected":70,"numAtRisk":924}]},{"term":"Plasmacytoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Precursor t-lymphoblastic lymphoma/leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Renal neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Rhabdomyosarcoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Squamous cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"T-cell lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Testicular cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Testis cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Tumour pain","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":924}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cerebral ischaemia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cerebral thrombosis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cerebrospinal fistula","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Demyelinating polyneuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Disturbance in attention","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Embolic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Facial paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Generalised tonic-clonic seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Guillain-barre syndrome","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Hemiparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Metabolic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Optic neuritis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Paraplegia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Parkinsonism","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Post herpetic neuralgia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Radicular pain","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Sciatica","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Spinal cord compression","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Status epilepticus","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Vith nerve paralysis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Abortion missed","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":924}]},{"term":"Drug use disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hallucination","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":924}]},{"term":"Bladder neck obstruction","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Cystitis haemorrhagic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hydronephrosis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Renal colic","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Renal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Renal impairment","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Prostatitis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Acute promyelocytic leukaemia differentiation syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Acute pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Acute respiratory distress syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Asthmatic crisis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Emphysema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Haemoptysis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hiccups","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Interstitial lung disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Lung disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Organising pneumonia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pneumonitis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":924}]},{"term":"Pulmonary congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":922},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":924}]},{"term":"Pulmonary haemorrhage","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pulmonary mass","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Pulmonary thrombosis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Tonsillar hypertrophy","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Cutaneous vasculitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Parapsoriasis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Psoriasis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Skin ulcer","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":924}]},{"term":"Toxic skin eruption","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Circulatory collapse","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":922},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":924}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hypertensive crisis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Peripheral artery thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Shock haemorrhagic","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":922},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":924}]},{"term":"Venous thrombosis limb","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":922},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":924}]}],"otherEvents":[{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":303,"numAffected":238,"numAtRisk":922},{"groupId":"EG001","numEvents":134,"numAffected":117,"numAtRisk":924}]},{"term":"Erythema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":422,"numAffected":304,"numAtRisk":922},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":924}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":754,"numAffected":509,"numAtRisk":922},{"groupId":"EG001","numEvents":496,"numAffected":341,"numAtRisk":924}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":293,"numAffected":238,"numAtRisk":922},{"groupId":"EG001","numEvents":235,"numAffected":185,"numAtRisk":924}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":391,"numAffected":304,"numAtRisk":922},{"groupId":"EG001","numEvents":215,"numAffected":170,"numAtRisk":924}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":718,"numAffected":485,"numAtRisk":922},{"groupId":"EG001","numEvents":327,"numAffected":236,"numAtRisk":924}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1327,"numAffected":757,"numAtRisk":922},{"groupId":"EG001","numEvents":103,"numAffected":84,"numAtRisk":924}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":224,"numAffected":192,"numAtRisk":922},{"groupId":"EG001","numEvents":66,"numAffected":57,"numAtRisk":924}]},{"term":"Swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":233,"numAffected":168,"numAtRisk":922},{"groupId":"EG001","numEvents":10,"numAffected":9,"numAtRisk":924}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","phone":"866-435-7343"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09","removedCountries":["Brazil","India"]},"conditionBrowseModule":{"meshes":[{"id":"D006562","term":"Herpes Zoster"}],"ancestors":[{"id":"D000073618","term":"Varicella Zoster Virus Infection"},{"id":"D006566","term":"Herpesviridae Infections"},{"id":"D004266","term":"DNA Virus Infections"},{"id":"D014777","term":"Virus Diseases"},{"id":"D007239","term":"Infections"}]}},"hasResults":true}